- Home
- EFSC vs NVCR Comparison
EFSC vs NVCR Comparison
Compare EFSC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EFSC | NVCR |
|---|---|---|
| Founded | 1988 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.3B |
| IPO Year | 1999 | 2015 |
Fundamental Metrics
Financial Performance| Metric | EFSC | NVCR |
|---|---|---|
| Price | $56.46 | $13.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $65.67 | $28.42 |
| AVG Volume (30 Days) | 147.3K | ★ 1.8M |
| Earning Date | 01-26-2026 | 10-30-2025 |
| Dividend Yield | ★ 2.26% | N/A |
| EPS Growth | ★ 8.68 | N/A |
| EPS | ★ 5.13 | N/A |
| Revenue | ★ $646,694,000.00 | $642,269,000.00 |
| Revenue This Year | $20.14 | $9.75 |
| Revenue Next Year | $5.15 | $5.62 |
| P/E Ratio | $11.06 | ★ N/A |
| Revenue Growth | 9.31 | ★ 11.17 |
| 52 Week Low | $45.22 | $10.70 |
| 52 Week High | $62.60 | $34.13 |
Technical Indicators
Market Signals| Indicator | EFSC | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 59.20 | 60.37 |
| Support Level | $55.09 | $10.79 |
| Resistance Level | $58.25 | $13.94 |
| Average True Range (ATR) | 1.31 | 0.61 |
| MACD | 0.32 | 0.22 |
| Stochastic Oscillator | 67.44 | 80.48 |
Price Performance
Historical ComparisonAbout EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.